News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
391,072 Results
Type
Article (26136)
Company Profile (290)
Press Release (364646)
Multimedia
Podcasts (60)
Webinars (8)
Section
Business (114327)
Career Advice (1649)
Deals (18532)
Drug Delivery (66)
Drug Development (64984)
Employer Resources (98)
FDA (14050)
Job Trends (8304)
News (214136)
Policy (23392)
Tag
Academia (1427)
Academic (1)
Accelerated approval (6)
Adcomms (16)
Allergies (71)
Alliances (27340)
ALS (74)
Alzheimer's disease (1144)
Antibody-drug conjugate (ADC) (108)
Approvals (14066)
Artificial intelligence (165)
Autoimmune disease (22)
Automation (5)
Bankruptcy (182)
Best Places to Work (7029)
BIOSECURE Act (12)
Biosimilars (67)
Biotechnology (235)
Bladder cancer (64)
Brain cancer (22)
Breast cancer (199)
Cancer (1768)
Cardiovascular disease (136)
Career advice (1392)
Career pathing (18)
CAR-T (129)
Cell therapy (367)
Cervical cancer (15)
Clinical research (53007)
Collaboration (612)
Compensation (296)
Complete response letters (17)
COVID-19 (1959)
CRISPR (44)
C-suite (189)
Cystic fibrosis (88)
Data (1817)
Decentralized trials (1)
Denatured (12)
Depression (42)
Diabetes (196)
Diagnostics (2746)
Digital health (9)
Diversity (3)
Diversity, equity & inclusion (21)
Drug discovery (97)
Drug pricing (76)
Drug shortages (14)
Duchenne muscular dystrophy (93)
Earnings (49613)
Editorial (31)
Employer branding (14)
Employer resources (84)
Events (58815)
Executive appointments (531)
FDA (15270)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (561)
Gene editing (104)
Generative AI (16)
Gene therapy (291)
GLP-1 (513)
Government (3295)
Grass and pollen (2)
Guidances (53)
Healthcare (10581)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (109)
Indications (27)
Infectious disease (2068)
Inflammatory bowel disease (130)
Inflation Reduction Act (10)
Influenza (39)
Intellectual property (81)
Interviews (351)
IPO (10138)
IRA (40)
Job creations (1645)
Job search strategy (1160)
Kidney cancer (7)
Labor market (16)
Layoffs (332)
Leadership (11)
Legal (3315)
Liver cancer (61)
Lung cancer (252)
Lymphoma (123)
Machine learning (4)
Management (33)
Manufacturing (200)
MASH (61)
Medical device (6074)
Medtech (6077)
Mergers & acquisitions (8749)
Metabolic disorders (508)
Multiple sclerosis (63)
NASH (13)
Neurodegenerative disease (78)
Neuropsychiatric disorders (27)
Neuroscience (1616)
NextGen: Class of 2025 (3418)
Non-profit (1845)
Now hiring (24)
Obesity (251)
Opinion (185)
Ovarian cancer (69)
Pain (62)
Pancreatic cancer (63)
Parkinson's disease (133)
Partnered (10)
Patents (160)
Patient recruitment (93)
Peanut (41)
People (33320)
Pharmaceutical (49)
Pharmacy benefit managers (8)
Phase I (17236)
Phase II (23561)
Phase III (17439)
Pipeline (1065)
Policy (115)
Postmarket research (1558)
Preclinical (6998)
Press Release (37)
Prostate cancer (75)
Psychedelics (35)
Radiopharmaceuticals (239)
Rare diseases (338)
Real estate (2361)
Recruiting (41)
Regulatory (18701)
Reports (20)
Research institute (1332)
Resumes & cover letters (241)
Rett syndrome (4)
RNA editing (5)
RSV (26)
Schizophrenia (68)
Series A (101)
Series B (67)
Service/supplier (1)
Sickle cell disease (47)
Special edition (12)
Spinal muscular atrophy (140)
Sponsored (19)
Startups (2256)
State (1)
Stomach cancer (4)
Supply chain (36)
Tariffs (34)
The Weekly (47)
Vaccines (518)
Venture capitalists (34)
Weight loss (142)
Women's health (17)
Worklife (7)
Date
Today (14)
Last 7 days (656)
Last 30 days (1819)
Last 365 days (24294)
2025 (7932)
2024 (25858)
2023 (28797)
2022 (35788)
2021 (37450)
2020 (33959)
2019 (26012)
2018 (19793)
2017 (20097)
2016 (17654)
2015 (21042)
2014 (15453)
2013 (11544)
2012 (12209)
2011 (12583)
2010 (11760)
Location
Africa (461)
Alabama (46)
Alaska (2)
Arizona (92)
Arkansas (7)
Asia (25535)
Australia (5716)
California (4584)
Canada (1461)
China (433)
Colorado (186)
Connecticut (190)
Delaware (124)
Europe (51599)
Florida (620)
Georgia (152)
Idaho (25)
Illinois (326)
India (14)
Indiana (167)
Iowa (3)
Japan (106)
Kansas (72)
Kentucky (9)
Louisiana (9)
Maine (39)
Maryland (734)
Massachusetts (3575)
Michigan (110)
Minnesota (202)
Mississippi (1)
Missouri (42)
Montana (18)
Nebraska (7)
Nevada (30)
New Hampshire (36)
New Jersey (1348)
New Mexico (16)
New York (1272)
North Carolina (721)
North Dakota (6)
Northern California (2011)
Ohio (137)
Oklahoma (10)
Oregon (25)
Pennsylvania (940)
Puerto Rico (7)
Rhode Island (24)
South America (557)
South Carolina (7)
Southern California (1752)
Tennessee (39)
Texas (560)
United States (16666)
Utah (82)
Virginia (108)
Washington D.C. (44)
Washington State (420)
West Virginia (2)
Wisconsin (28)
391,072 Results for "australian therapeutic goods administration".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults
April 1, 2025
·
4 min read
Drug Development
iECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506
iECURE, Inc. announced today that the Australian Therapeutic Goods Administration (TGA) has approved the Company’s Clinical Trial Notification (CTN) for ECUR-506 (formerly GTP-506), an investigational therapy in development for the treatment of Ornithine Transcarbamylase (OTC) deficiency in pediatric (or neonatal) patients.
December 13, 2023
·
7 min read
Press Releases
Parse Biosciences Expands Global Reach with the South Australian Genomics Centre as Certified Service Provider
March 21, 2025
·
2 min read
Press Releases
Montai Therapeutics Appoints Allison Bogosian, JD, as Chief People and Administrative Officer
April 28, 2025
·
2 min read
Press Releases
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Botulinum Toxin Treatment for Hyperhidrosis
February 26, 2025
·
5 min read
Press Releases
Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial
January 29, 2025
·
6 min read
Policy
Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro
Venus Concept Inc., a global medical aesthetic technology leader, announced that it has Therapeutic Goods Administration clearance in Australia to market the Venus Versa Pro system.
April 3, 2024
·
3 min read
Policy
Neurophth Secures Australian Approval for Ophthalmic Gene Therapy
Neurophth Therapeutics, a leader in in-vivo gene therapy for ophthalmic diseases in China, announced the Australian Therapeutic Goods Administration has registered and approved its candidate drug, NFS-05, for clinical trials targeting Autosomal Dominant Optic Atrophy.
September 6, 2023
·
3 min read
Press Releases
Skyhawk Therapeutics Receives Australian Regulatory Approval to Extend SKY-0515 Treatment Duration in Phase 1 Huntington’s Disease Patient Trial
December 10, 2024
·
3 min read
Immuron Presentation Australian Biologics Festival 2024
Immuron Limited, an Australian based and globally integrated biopharmaceutical company is pleased to advise our Research & Development Manager, Joanne Casey, PhD will be presenting at the Australian Biologics Festival 2024 on Wednesday, 21st February in Melbourne, Australia.
February 21, 2024
·
1 min read
1 of 39,108
Next
